Cyclin-Dependent Kinase Inhibitor p57 [inhibitor p57 cyklin-dependentní kinasy]
- Terms
-
cyklin-dependentní kinasy - inhibitor 1C
cyklin-dependentní kinasy - inhibitor p57
inhibitor p57 cyklin dependentní kinázy
inhibitor p57 cyklin-dependentní kinázy
protein CDKN1C
protein p57 KIP2
protein p57KIP2
-
CDKN1C Protein
Cyclin Kinase Inhibitor Protein 2
Cyclin-Dependent Kinase Inhibitor 1C
p57 KIP2 Protein
p57KIP2 Protein
A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.
- DUI
- D050761 MeSH Browser
- CUI
- M0245969
- History note
- 2006(1995)
- Public note
- 2006; CYCLIN-DEPENDENT KINASE INHIBITOR P57 was indexed under NUCLEAR PROTEINS 1995-2005
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
CDKN1C protein, human Chemical MeSH Browser
Cdkn1c protein, mouse Chemical MeSH Browser